With NYC 'hackathon,' Médecins Sans Frontières aims to enlist Pfizer, GSK shareholders in its battle over vaccine prices

MSF is hosting a "hackathon" in New York City as a means to bring Pfizer and GSK shareholders in on its vaccine price-fighting efforts.

Médecins Sans Frontières has protested pneumococcal vaccine pricing from Pfizer and GlaxoSmithKline for years, resulting in incremental wins for the charity along the way. Now, the group is taking an early step to mobilize shareholders to pressure the drug giants via a “hackathon” in New York City.

The event is designed to bring together “developers, designers, and strategists” to create an online platform to help people determine whether or not they’re holding Pfizer or GSK stocks in their retirement accounts.


The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

Then, shareholders can join the price-fighting efforts. “This data is already public but not easy to access,” according to a MSF spokesperson.

RELATED: Pfizer, GSK targeted for vaccine pricing in MSF Twitter spree

“Once people know where their money is, they can use their voice as shareholders to demand that the company do the right thing and make this vaccine affordable for everyone,” she continued.

RELATED: GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings

Pfizer recently committed to a big boost in its humanitarian efforts with Prevnar, and GSK last year reduced the price of its Synflorix for refugees. But MSF is not letting up, and last month launched a Twitter storm asking the companies to lower the prices across the board.

MSF’s event comes on the heels of a first-of-a-kind Access to Vaccines Index, documenting the strides that have been made—and work left to do—in vaccine access around the globe.

Suggested Articles

Leading Indian drugmakers Sun Pharma, Cipla, Aurobindo and Dr. Reddy's are all trying to expand their presences in China.

New Gilead CEO Daniel O’Day has already replaced some key leaders at the company, but he’s not stopping there with the executive overhaul.

The FDA lambasted Strides Pharma in a warning letter after inspectors found testing records in the trash and in bags by a shredder.